Andrew Nixon

18PUBLICATIONS
111CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 03, 2025
Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202).

Emily K Bergsland, Susan Geyer, Timothy R Asmis

|Jan 21, 2025
Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial).

Husam A Alqaisi, David E Cohn, Jing-Yi Chern

|Oct 14, 2024
Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants.

Yingmiao Liu, Jiatong Li, Jing Lyu

|Jun 18, 2024
Incorporating Molecular Data Into Treatment Decision Making in Gastroesophageal and Pancreaticobiliary Cancers: Timing and Strategies.

Andrew Hall, Sarah R Brown, Niharika B Mettu

|Apr 01, 2024
Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies.

Akram Yazdani, Azam Yazdani, Raul Mendez-Giraldez

|Feb 16, 2024
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma.

Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon

Pageof 3

Frequent Collaborators

5 joint publications

Alan P Venook

4 joint publications

Eileen M O'Reilly

4 joint publications

Jeffrey A Meyerhardt

3 joint publications

Herbert I Hurwitz